Dr. Alexander Bick is a physician–scientist specializing in Medical Genetics and Genetic Medicine, serving as Director (Division Chief) of the Division of Genetic Medicine at Vanderbilt University Medical Center. He leads clinical and research programs in human genomics, with a focus on translating genetic discoveries into improved patient care. His research examines how inherited germline variants interact with acquired somatic mutations to drive disease, focusing on clonal hematopoiesis, cardiovascular disease, and the genetic basis of blood cancers. He develops algorithms to understand why only a subset of pre-cancerous cells progress to malignancy and investigates genetic determinants of heart disease. Dr. Bick earned his MD (2016) and PhD in Genetics (2014) from Harvard University and completed an Internal Medicine residency at Massachusetts General Hospital. His prior academic and research roles span Harvard University, Massachusetts General Hospital, and Vanderbilt University. His honors include the 2025 Moreton Research Award and election to the American Society for Clinical Investigation (2025), the 2024 Hevolution/AFAR New Investigator Award in Aging Biology and Geroscience Research, the 2022 Pew Charitable Trusts Stewart Scholar for Cancer Research distinction, the 2020 Burroughs Wellcome Fund Career Award for Medical Scientists, and recognition as a 2015 “30 Under 30 in Healthcare.”
Division Chief
Medical School
2016
Residency